Showing results (101-110 of 269) with videos related to

Sort By:
Pageof 27
BMC Public Health|January 21, 2022
Prevalence and the associated factors of hepatitis B and hepatitis C viral infections among HIV-positive individuals in same-day antiretroviral therapy initiation program in Bangkok, ThailandSupanat Thitipatarakorn, Tanat Chinbunchorn, Jitsupa Peelay, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 10, 2018
Smoking and Accelerated Lung Function Decline in HIV-Positive Individuals: A Secondary Analysis of the START Pulmonary SubstudyDavid M MacDonald, Anne C Melzer, Gary Collins, et al.
AIDS (London, England)|April 26, 2011
Thai HIV-1-infected women do not require a dose increase of lopinavir/ritonavir during the third trimester of pregnancyReshmie A Ramautarsing, Jasper van der Lugt, Meena Gorowara, et al.
AIDS (London, England)|November 8, 2023
A study of the pharmacokinetics, safety, and efficacy of bictegravir/emtricitabine/tenofovir alafenamide in virologically suppressed pregnant women with HIVHaeyoung Zhang, Jason T Hindman, Ludwig Lin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 21, 2023
Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis With Liver Fibrosis as Predictors of New-Onset Diabetes Mellitus in People With HIV: A Longitudinal Cohort StudyWin Min Han, Tanakorn Apornpong, Hay Mar Su Lwin, et al.
Journal of Virus Eradication|November 30, 2020
Characteristics of suboptimal immune response after initiating antiretroviral therapy among people living with HIV with a pre-treatment CD4 T cell count 3 in ThailandWin Min Han, Sasiwimol Ubolyam, Tanakorn Apornpong, et al.
Southern African Journal of HIV Medicine|August 9, 2019
Switching at Low HIV-1 RNA into Fixed Dose Combinations: TDF/FTC/RPV is non-inferior to TDF/FTC/EFV in first-line suppressed patients living with HIVPaula Munderi, Edwin Were, Anchalee Avihingsanon, et al.
AIDS Research and Therapy|March 13, 2012
Assessment of HBV flare in a randomized clinical trial in HIV/HBV coinfected subjects initiating HBV-active antiretroviral therapy in ThailandAnchalee Avihingsanon, Gail V Matthews, Sharon R Lewin, et al.
Antiviral Therapy|August 24, 2013
Decline in serum 25 hydroxyvitamin D levels in HIV-HBV-coinfected patients after long-term antiretroviral therapyAnchalee Avihingsanon, Tanakorn Apornpong, Reshmie A Ramautarsing, et al.
Open Forum Infectious Diseases|May 25, 2026
Renal Outcomes in People With HIV-1 and Renal Impairment Treated With Bictegravir/Emtricitabine/Tenofovir Alafenamide: Integrated Analysis From 9 Phase 3/3b Clinical TrialsFrank A Post, David Wohl, Geoffroy Liegeon, et al.
Pageof 27